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Introduction
Postoperative vomiting (POV) is a source of distress
for patients after anesthesia and surgery and may delay
discharge from, or cause readmission to, hospital.1,2
Risk factors associated with POV include female gen-
der, nonsmoking status, history of POV or motion sick-
ness, extended duration of anesthesia, postoperative
opioid use, and age.3 Compared with general anes-
thesia, regional anesthesia causes a lower incidence of
POV for the avoidance usage of volatile anesthetics or
neostigmine.3–6 From our previous study, we found
that female gender is the only risk factor for POV in
patients undergoing lower-limb surgery with postop-
erative patient-controlled epidural analgesia (PCEA).7
The incidence rate of POV in our previous study was
< 10%. This rate seems fairly low in comparison with
that of other studies.8–11 Underestimation of the inci-
dence of POV was possible. Hence, we conducted this
study to investigate the potential risk factors associ-
ated with POV during the course of PCEA. Subgroup
analysis for female gender was also performed to eval-
uate the effect of these factors on POV in this higher
risk group.
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Background: Postoperative pain and postoperative vomiting (POV) are both sources of distress in the postoperative
period. Patient-controlled epidural analgesia (PCEA) is used in patients undergoing lower extremity surgery to improve
postoperative quality but is accompanied by a certain incidence of vomiting. We wanted to determine the risk factors of
POV in patients using PCEA with the aim of improving the quality of the postoperative period.
Methods: We conducted a retrospective study to analyze the risk factors among patients using PCEA after lower-limb
surgery under regional anesthesia. A total of 195 patients (91 males, 104 females) were enrolled. They were catego-
rized into 2 groups: vomiting and non-vomiting. We found that female gender predominated in the vomiting group. Hence,
we analyzed the female subgroup in order to find the risk factors of vomiting in the female PCEA population.
Results: Female gender was the most significant factor related to vomiting (crude OR, 11.55; 95% CI, 4.88–27.33).
From analysis of the female subgroup, puncture site (OR, 4.07; 95% CI, 1.41–11.79), catheter length in the epidural
space (OR, 0.28; 95% CI, 0.16–0.50) and patient’s height (OR, 1.07; 95% CI, 1.00–1.14) were also factors for vomiting,
i.e. higher epidural catheter puncture site, shorter length in the epidural space, and greater height caused a higher 
incidence of POV.
Conclusion: The most important risk factor for POV in patients using PCEA was female gender. Among the female sub-
group, the risk factors for POV included higher epidural catheter puncture site, shorter length in the epidural space and
greater body height. [J Chin Med Assoc 2009;72(4):183–187]
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Methods
This study was conducted at Taipei Veterans General
Hospital, a tertiary medical center in Taiwan. Ethical
approval was obtained from our Institutional Review
Board (VGHIRB No. 96-10-07A). We collected data
on orthopedic surgical patients consenting to epidural
analgesia from January to March 2007. Patients who
underwent operations involving the lower extremities
under combined spinal-epidural anesthesia with post-
operative PCEA were enrolled in the analysis. Patients
with missing demographic data or malfunctioning epi-
dural catheters were excluded. Epidural catheters were
placed when performing spinal anesthesia before oper-
ation with paramedian approach in an intervertebral
space corresponding to the dermatome level of the
surgical incision, with the patient in the lateral decubi-
tus position. After local infiltration with 2% lidocaine,
spinal anesthesia was performed and followed by epi-
dural catheter placement. An 18-gauge Tuohy needle
and 20-gauge epidural catheter were employed. Epi-
dural space was identified with the loss-of-resistance
technique, and the epidural catheter was placed 5–8 cm
into the epidural space according to the preference 
of the anesthesiologist. The catheter entry point was
dressed with transparent adhesive dressing for inspec-
tion of catheter dislodgment or signs of local infection.
All epidural catheters were confirmed not to have kink-
ing or malposition. If the epidural catheter had an
obstruction, or if intrathecal or intravascular migration
was noted, the catheter was removed and the patient
was excluded from this study. Regional anesthesia was
performed with intrathecal hyperbaric 0.5% bupiva-
caine 12–15 mg and epidural top-up dose of 6–10 mL
bupivacaine (0.5%), with fentanyl (5 μg/mL) given if
the sensory block regressed before the end of opera-
tion. Otherwise, epidural loading dose with 6–10 mL
bupivacaine (0.25%) and fentanyl (5 μg/mL) was
administered at the end of operation.
As soon as patients arrived in the postanesthesia care
unit, they were educated on how to use the patient-
controlled analgesia pump (Aim® Plus System; Abbott
Laboratories, North Chicago, IL, USA), and the back-
ground infusion was started. The infused drug com-
prised local anesthetic (0.1% bupivacaine) and opioid
(1 μg/mL fentanyl). Initial PCEA settings were a
background infusion of 4 mL/hr with a PCEA bolus
of 2 mL and lockout interval of 20–30 minutes. Pain
intensity was assessed using an 11-point verbal analog
scale (VAS) (0 = no pain to 10 = worst pain imaginable).
Inadequate resting analgesia (VAS≥4) was secured with
a 5-mL top-up dose of the infusion mixture, and the
background infusion dose was adjusted to 5–6 mL/hr.
All patients were visited at least once a day by the staff
of the acute pain service (APS) and whenever clini-
cally needed. Any complaint of numbness, nausea,
vomiting, pruritus or other adverse effects related to
PCEA was treated with 1–2 mL/hr decrease in con-
tinuous dose based on the clinical severity, and it was
recorded in the PCEA recording charts. The definitions
of factors used in this article are shown in Table 1.
Recruited patients were categorized into the vomit-
ing or non-vomiting group according to their response
to PCEA. Patients who experienced vomiting were
placed in the vomiting group and patients who did
not vomit during the PCEA period were placed in the
non-vomiting group.
Continuous data are presented as mean ± standard
deviation (SD), and categorical data are expressed as
number with percentage. Independent t test or χ2 test
was used to compare patients’ characteristics and vari-
ables related to PCEA usage of the 2 groups. Any 
p value < 0.05 was considered statistically significant.
Logistic regression analyses were used for odds ratio
(OR) estimation. After univariate analysis, forward
stepping of variables was performed with pre-assigned
p values equal to 0.05 for controlling the stepping
retention. The OR estimates are exhibited with their
95% confidence intervals (CI). Subgroup analysis was
also conducted to evaluate the risk factors for vomit-
ing in females. Receiver operating characteristic (ROC)
curve was used to assess the fit of the model. All sta-
tistical analyses were carried out using SPSS version
15.0 (SPSS Inc., Chicago, IL, USA) for Windows.
Results
A total of 195 patients (91 men, 104 women) were
enrolled in the study. The demographic data and vari-
ables related to PCEA usage were compared between
the vomiting and non-vomiting groups (Table 2). The
incidence of POV in our study was 30% (51 females,
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Table 1. Definitions of factors
Factor Definition
Length Epidural catheter length in the epidural space
Height Patient body height
Weight Patient body weight
Bolus dose The first loading dose of patient-controlled 
analgesia
Puncture The epidural catheter insertion site. Epidural 
site puncture site above L2/L3 (above L2/3 = 1; 
L3/4, L4/5 = 0)
7 males). The length of the epidural catheter, patient
height and sex distribution were significantly different
between the vomiting and non-vomiting groups.
Table 3 shows the crude and adjusted ORs of
some potential risk factors related to vomiting induced
by PCEA. Univariate analyses showed that female sex,
catheter length in the epidural space, and patient
height and weight were associated with vomiting dur-
ing the course of PCEA. Female sex was the most 
significant risk factor related to vomiting (crude OR,
11.55; 95% CI, 4.88–27.33). In contrast, longer cath-
eter length in the epidural space, and patient body
height and weight played protective roles in POV.
The crude OR of catheter length in the epidural space
was 0.54 (95% CI, 0.38–0.77). The crude OR of body
height and weight were 0.94 and 0.97, respectively.
Factors related to PCEA dosage, like bolus dose, were
not associated with increased risk of vomiting. Other
factors did not have statistically significant influence
on vomiting.
The results of adjusted OR of significant factors
after forward model selection are also presented in
Table 3. Female sex remained the most significant risk
factor related to PCEA-induced vomiting. The adjusted
OR of female sex increased to 66.37 (95% CI, 14.93–
294.97). Other risk factors after adjustment included
higher epidural puncture site (intervertebral space be-
tween L2 and L3 vs. other lower intervertebral space:
OR, 4.07; 95% CI, 1.41–11.79) and taller body height
(OR, 1.07; 95% CI, 1.00–1.14). On the contrary,
longer catheter length in the epidural space exerted a
protective effect (OR, 0.28; 95% CI, 0.16–0.50).
Subgroup analysis results between vomiting and
non-vomiting for female patients are displayed in
Table 4. The epidural catheter length, height and total
knee replacement were significantly different between
the 2 groups. Figure 1 illustrates the ROC curve of the
final selected model. The area under the curve (AUC)
was about 0.87 (95% CI, 0.81–0.93), indicating that
the selected model fit the observed data well. Table 5
presents the results of female subgroup analysis. There
were 3 factors related to POV in females, including
higher puncture site (OR, 9.52; 95% CI, 1.91–47.51),
longer catheter length in the epidural space (OR, 0.08;
95% CI, 0.02–0.30), and taller patient height (OR,
1.15; 95% CI, 1.05–1.25).
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Table 2. Demographic data of the enrolled patients*
Non-vomiting (n = 137) Vomiting (n = 58) p Total (n = 195)
Age (yr) 69.5 ± 12.9 69.6 ± 10.9 0.954 69.6 ± 12.3
Length (cm)† 6.8 ± 0.9 6.3 ± 0.8 < 0.001§ 6.7 ± 0.9
Height (cm) 159.6 ± 10 154.8 ± 6.5 < 0.001§ 158.2 ± 9.3
Weight (kg) 66.3 ± 11.9 62.9 ± 11.2 0.06 65.3 ± 11.7
BMI (kg/m2) 26 ± 4.2 26.2 ± 4.1 0.84 26.1 ± 4.1
Bolus dose (mL) 2 ± 0.3 2 ± 0.2 0.298 2 ± 0.3
Sex (female) 53 (38.7) 51 (87.9) < 0.001§ 104 (53.3)
Total knee replacement 92 (67.2) 41 (70.7) 0.628 133 (68.2)
Puncture site‡ 109 (79.6) 49 (84.5) 0.423 158 (81.0)
*Data presented as mean ± standard deviation or n (%); †catheter length indwelling in the epidural space; ‡epidural catheter insertion site above the level of
the 3rd lumbar vertebra; §total knee replacement, p < 0.05. BMI = body mass index.
Table 3. Crude and adjusted OR of potential risk factors related to PCEA-induced vomiting
Crude 95% CI p Adjusted 95% CI p
OR Lower Upper (univariate) OR Lower Upper (multivariate)
Sex (female) 11.55 4.88 27.33 < 0.001* 66.37 14.93 294.97 < 0.001*
Age (yr) 1.00 0.98 1.03 0.953
Total knee replacement 1.18 0.60 2.30 0.628
Site 1.40 0.61 3.19 0.424 4.07 1.41 11.79 0.01*
Length (cm) 0.54 0.38 0.77 0.001* 0.28 0.16 0.50 < 0.001*
Height (cm) 0.94 0.91 0.98 0.001* 1.07 1.00 1.14 0.045*
Weight (kg) 0.97 0.95 1.00 0.062
Bolus dose (mL) 0.57 0.19 1.67 0.302
BMI (kg/m2) 1.01 0.94 1.09 0.839
*p < 0.05. OR = odds ratio; PCEA = patient-controlled epidural analgesia; CI = confidence interval; BMI = body mass index.
Discussion
From the analyses, we found that the risk factor for
vomiting in female patients using PCEA was higher
epidural catheter puncture site. Longer threaded epi-
dural catheter exerted a protective effect. The overall
incidence of POV in this study was 30%. The inci-
dence of POV in our last study was 9.7%.7 It seemed
that distinct investigators caused underestimation of
the incidence of POV in our previous study.
The analgesia mechanism of fentanyl in the epi-
dural space is not clearly understood. It is presumed
that the lipophilic opioids injected into the epidural
space work by spinal effect and systemic uptake.12–17
Compared with hydrophilic opioids such as morphine,
the advantage of fentanyl in the epidural space is char-
acterized by its lipophilic nature, which exerts segmen-
tal effect other than rostral spread to cause side effects,
such as vomiting.4 The side effect of vomiting from
the use of fentanyl in the epidural space is believed 
to be induced by systemic absorption reaching the
chemoreceptor trigger zone.
The ideal epidural catheter location is regarded to
be congruent to the incisional dermatome to offer bet-
ter analgesia and fewer side effects. In lower-extremity
surgery, the ideal congruent epidural catheter location
is L1–L4. If the indwelling epidural catheter lengths
are all 5 cm, the higher insertion site theoretically means
a higher tip position. Our PCEA analgesic agent in-
cluded local anesthetic agent (0.1% bupivacaine) and
opioid (1 μg/mL fentanyl). Opioid is thought to be
the contributor to POV. But the mechanism of vom-
iting is complex, and vagus nerve also plays a role in
provoking vomiting.18 The epidural local anesthetic’s
precise location of action is not clearly understood;
the potential sites include the spinal nerve roots, dorsal
root ganglion and the spinal cord itself.14 The epi-
dural local anesthetics may cause sympatholytic effect
and consequently unopposed parasympathetic tone.
Vagal tone dominance may increase the incidence of
POV.4,18 The higher the epidural catheter tip, the more
extended the range of sympathetic blockage, which
causes POV. Since drug spread in the epidural space 
is not predictable,19 the larger volume did not make
the higher level blockage. So the bolus dose is not
selected into the final regression model.
In the univariate analysis, the crude OR for patient
height was 0.94 (95% CI, 0.91–0.98). It seemed that
patients of shorter stature had a higher possibility of
PCEA-induced vomiting. But after multivariate selec-
tion, the adjusted OR became 1.07 (95% CI, 1.00–
1.14). On average, the body height of females is gen-
erally shorter than that for males. After excluding the
effect of sex interference by multivariate logistic regres-
sion, we found that the taller patients had a higher
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Table 4. Subgroup analysis for female sex*
Non-vomiting Vomiting 
p
(n = 53) (n = 51)
Age (yr) 70.2 ± 8.4 67.7 ± 10.0 0.169
Length (cm)† 7.0 ± 0.6 6.4 ± 0.7 < 0.001§
Height (cm) 150.5 ± 5.3 154.0 ± 6.2 0.003§
Weight (kg) 61.1 ± 9.1 63.2 ± 11.4 0.303
BMI (kg/m2) 27.0 ± 4.1 26.6 ± 4.1 0.596
Bolus dose (mL) 2.0 ± 0.2 2.0 ± 0.2 0.845
Total knee 46 (86.8) 36 (70.6) 0.043§
replacement
Puncture site‡ 37 (69.8) 42 (82.4) 0.135
*Data presented as mean ± standard deviation or n (%); †catheter length
indwelling in the epidural space; ‡epidural catheter insertion site above the
level of the 3rd lumbar vertebra; §p < 0.05. BMI = body mass index.
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Figure 1. Receiver operating characteristic curve of the final
selected model. The area under the curve is about 0.87, with
95% confidence intervals of 0.81–0.93. Diagonal segments are
produced by ties.
Table 5. Result of female subgroup analysis*
Factor
Adjusted 95% CI p
OR Lower Upper (multivariate)
Site 9.52 1.91 47.51 0.006†
Length (cm) 0.08 0.02 0.30 < 0.001†
Height (cm) 1.15 1.05 1.25 0.002†
*There were 3 factors related to PCEA-induced vomiting in females, includ-
ing puncture site, catheter length, and patient height; †p < 0.05. OR = odds
ratio; CI = confidence interval; PCEA = patient-controlled epidural analgesia.
incidence of vomiting. On the other hand, both crude
and adjusted ORs of height were very close to 1.
Either our data were insufficient to provide a definite
conclusion or patient height (compared with other
factors) only played a minor role in PCEA-induced
vomiting in the final regression model.
Why was the longer epidural catheter length a pro-
tective factor? We know that longer epidural catheter
length insertion increases the risk of intravenous inser-
tion, intrathecal migration, knotting or unilateral sen-
sory analgesia.20 From our literature review, there is no
study on the relation between epidural catheter length
and the incidence of POV. This is a remarkable find-
ing, but the exact protective mechanism is not clear.
The relationship between the incidence of POV in
PCEA and epidural catheter length awaits further
investigation.
In conclusion, the incidence of vomiting in patients
with PCEA was 30% in this study. The predominant
risk factor is female sex. Among the female popula-
tion, we found that taller stature and higher epidural
catheter puncture level were risk factors for vomiting;
longer threaded catheter length was a protective fac-
tor for POV in patients using PCEA. The relationship
between catheter length and incidence of POV needs
further study. In daily practice, to reduce the incidence
of POV, we may choose a lower puncture site for epi-
dural catheter insertion, especially in the taller female
population.
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